Melanoma Evidence & Self-Care · education / decision-support

← Evidence library

BIB_093

Moncrieff MD et al. MelMarT-II: A randomized trial comparing 1 cm vs 2 cm wide excision margins for primary cutaneous melanoma. ASCO 2023 / 2024. Forward-looking for 1–2 mm Breslow. [Tasks: 02, 03] Tier: 2 Grade: A Retrieved: 2026-05-06

Evidence grade
A
Tier
2
Cited by tasks
02, 03
Identifiers

Full extracted findings & patient-implication analysis: bibliography/BIB_093/findings.md (research corpus). This page is a short context summary — not individualised medical advice.